MicroTech Medical Hong Kong IPO Greeted with Yawns 微泰醫療香港上市遇冷
Diabetes device maker’s shares go largely unchanged in first four trading days despite attracting Invesco and two other mid-sized U.S. fund managers 盡管吸引了景順和其他兩家美國中型基金，這家糖尿病設備制造商的股價在前四個交易日基本沒有變化。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.